Sisram Medical Statistics

Total Valuation

Sisram Medical has a market cap or net worth of HKD 2.08 billion. The enterprise value is 2.00 billion.

Market Cap	2.08B
Enterprise Value	2.00B

Important Dates

The next estimated earnings date is Wednesday, May 21, 2025.

Earnings Date	May 21, 2025
Ex-Dividend Date	Aug 26, 2024

Share Statistics

Sisram Medical has 468.34 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	468.34M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.20%
Owned by Institutions (%)	0.56%
Float	340.09M

Valuation Ratios

The trailing PE ratio is 10.69 and the forward PE ratio is 6.62.

PE Ratio	10.69
Forward PE	6.62
PS Ratio	0.77
PB Ratio	0.55
P/TBV Ratio	1.38
P/FCF Ratio	8.85
P/OCF Ratio	8.11
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 5.73, with an EV/FCF ratio of 8.51.

EV / Earnings	10.27
EV / Sales	0.74
EV / EBITDA	5.73
EV / EBIT	9.32
EV / FCF	8.51

Financial Position

The company has a current ratio of 2.61, with a Debt / Equity ratio of 0.09.

Current Ratio	2.61
Quick Ratio	1.66
Debt / Equity	0.09
Debt / EBITDA	0.96
Debt / FCF	1.42
Interest Coverage	11.27

Financial Efficiency

Return on equity (ROE) is 6.03% and return on invested capital (ROIC) is 3.32%.

Return on Equity (ROE)	6.03%
Return on Assets (ROA)	2.79%
Return on Invested Capital (ROIC)	3.32%
Return on Capital Employed (ROCE)	5.20%
Revenue Per Employee	2.69M
Profits Per Employee	193,617
Employee Count	1,015
Asset Turnover	0.56
Inventory Turnover	1.64

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +22.03% in the last 52 weeks. The beta is 1.20, so Sisram Medical's price volatility has been higher than the market average.

Beta (5Y)	1.20
52-Week Price Change	+22.03%
50-Day Moving Average	4.31
200-Day Moving Average	3.66
Relative Strength Index (RSI)	47.28
Average Volume (20 Days)	1,071,769

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Sisram Medical had revenue of HKD 2.71 billion and earned 195.17 million in profits. Earnings per share was 0.42.

Revenue	2.71B
Gross Profit	1.68B
Operating Income	214.98M
Pretax Income	252.76M
Net Income	195.17M
EBITDA	302.22M
EBIT	214.98M
Earnings Per Share (EPS)	0.42

Full Income Statement

Balance Sheet

The company has 576.00 million in cash and 335.56 million in debt, giving a net cash position of 240.44 million or 0.51 per share.

Cash & Cash Equivalents	576.00M
Total Debt	335.56M
Net Cash	240.44M
Net Cash Per Share	0.51
Equity (Book Value)	3.77B
Book Value Per Share	7.70
Working Capital	1.19B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 256.97 million and capital expenditures -21.35 million, giving a free cash flow of 235.62 million.

Operating Cash Flow	256.97M
Capital Expenditures	-21.35M
Free Cash Flow	235.62M
FCF Per Share	0.50

Full Cash Flow Statement

Margins

Gross margin is 62.07%, with operating and profit margins of 7.93% and 7.20%.

Gross Margin	62.07%
Operating Margin	7.93%
Pretax Margin	9.32%
Profit Margin	7.20%
EBITDA Margin	11.14%
EBIT Margin	7.93%
FCF Margin	8.69%

Dividends & Yields

This stock pays an annual dividend of 0.13, which amounts to a dividend yield of 2.83%.

Dividend Per Share	0.13
Dividend Yield	2.83%
Dividend Growth (YoY)	-8.67%
Years of Dividend Growth	n/a
Payout Ratio	37.61%
Buyback Yield	-0.21%
Shareholder Yield	2.62%
Earnings Yield	9.36%
FCF Yield	11.31%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Sisram Medical has an Altman Z-Score of 2.32. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.32
Piotroski F-Score	n/a